This in turn triggers the body to mount an immune response against these proteins, including producing antibodies. When the vaccine is injected, the vector enters cells in the body and causes them to produce the spike protein on their surfaces. The viral vector, which is a nonreplicating form of a chimpanzee adenovirus (called ChAdOx1), was developed at Oxford’s Jenner Institute and was chosen for its safety and ability to induce a strong immune response in humans, as shown in early clinical trials for another coronavirus vaccine against Middle East respiratory syndrome. The spike protein is what enables the virus to enter cells and establish an infection. Its design is based on a recombinant viral vector that contains genetic material encoding the spike protein of the novel coronavirus (SARS-CoV-2).
The Oxford vaccine is being tested in the first SARS-CoV-2 vaccine trial conducted in the U.K. Its circulation has been aided primarily by Facebook groups that oppose vaccines and those known to promote conspiracy theories.
The article makes numerous claims about Bill Gates and the SARS-CoV-2 vaccine being developed by Oxford University researchers. SUMMARY This article, published in late May 2020, received more than 280,000 views on Facebook and more than 24,000 interactions on social media.
#Bill gates vaccine production full#
FULL CLAIM: “Bill Gates’ shoddily-hastened vaccine has been determined to make all animal test subjects get COVID-19 when exposed to the virus“ Financial backing for the production of the Oxford vaccine has come from several sources other than the Bill and Melinda Gates Foundation, including the U.K. However, the researchers also detected viral genetic material in nasal passages in vaccinated monkeys, leading scientists to caution that the vaccine may provide only partial protection and may not prevent virus shedding and its spread to unvaccinated individuals. Preliminary results from small-scale animal studies suggest that the SARS-CoV-2 vaccine developed by Oxford researchers may protect against viral pneumonia after infection with the novel coronavirus.
0 kommentar(er)
